Olili, Leonarda .
HRN: 23-72-64 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/23/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
09/23/2023
09/29/2023
IV
2.25g
Q8
Intra-abdominal Infection
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes